Regencell Bioscience Holdings Limited
RGC
$31.60
-$2.74-7.98%
NASDAQ
| 06/30/2024 | 03/31/2024 | 06/30/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -31.16% | -31.16% | -29.56% | -- | -- |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 170.44% | 170.44% | 104.71% | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -25.35% | -25.35% |
| Total Current Assets | -30.18% | -30.18% | -29.33% | -25.35% | -25.35% |
|
|
|||||
| Total Current Assets | -30.18% | -30.18% | -29.33% | -25.35% | -25.35% |
| Net Property, Plant & Equipment | -74.60% | -74.60% | -38.91% | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -9.95% | -9.95% | -5.07% | -33.91% | -33.91% |
| Total Assets | -33.15% | -33.15% | -29.95% | -26.18% | -26.18% |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | -20.75% | -20.75% | 4.63% | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -86.36% | -86.36% | 6.64% | -- | -- |
| Total Finance Division Other Current Liabilities | -20.75% | -20.75% | -32.48% | -- | -- |
| Total Other Current Liabilities | -20.75% | -20.75% | -32.48% | -- | -- |
| Total Current Liabilities | -68.10% | -68.10% | 5.04% | -- | -- |
|
|
|||||
| Total Current Liabilities | -68.10% | -68.10% | 5.04% | -- | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.97% | 1.97% | -92.95% | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -65.29% | -65.29% | -32.59% | -35.93% | -35.93% |
|
|
|||||
| Common Stock & APIC | 1.53% | 1.53% | 3.24% | -25.51% | -25.51% |
| Retained Earnings | -24.84% | -24.84% | -51.30% | -- | -- |
| Treasury Stock & Other | 47.17% | 47.17% | -- | -- | -- |
| Total Common Equity | -31.68% | -31.68% | -29.51% | -25.51% | -25.51% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -31.68% | -31.68% | -29.51% | -25.51% | -25.51% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -365.58% | -- | -- |
| Total Equity | -31.45% | -31.45% | -29.81% | -25.51% | -25.51% |
|
|
|||||